Sara Buhrlage, Ph.D.

Sara joined the Dana-Farber Cancer Institute Cancer Biology and Harvard Medical School Biomolecular and Cellular Pharmacology faculty in 2015. Prior to making the move to an academic position Sara was a professional track scientist in Dana-Farber's medicinal chemistry core laboratory. In that role she collaborated with cancer biologists and clinicians to pharmacologically validate novel targets of disease in vitro and in vivo and to study mechanisms of disease and drug resistance. Sara received her PhD in organic chemistry from University of Michigan in 2008 under the direction of Professor Anna Mapp then trained for two years in medicinal chemistry at the Broad Institute before moving to Dana-Farber Cancer Institute. In addition to pursuing novel strategies for challenging drug targets Sara enjoys playing soccer, cooking and spending time with her husband and daughter.